Who Paid My Doc
A Multi-Centre, Single Arm, Open-Label Extension Study to Evaluate the
Research payments
$3,305,522
Through program year 2025, $3,305,522 in research payments was reported against A Multi-Centre, Single Arm, Open-Label Extension Study to Evaluate the, across 851 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $519,267 | 185 |
| 2024 | Research | $886,719 | 258 |
| 2023 | Research | $1,451,281 | 311 |
| 2022 | Research | $448,254 | 97 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- David Fuentes Boerne, TX Named on 68 payments
- Lawrence Sindel Mobile, AL Named on 23 payments
- Vandely Perez Miami, FL Named on 22 payments
- David Bernstein Cincinnati, OH Named on 22 payments
- Yamirka Sanchez Perez Hialeah, FL Named on 21 payments
- Jaime Landman Fort Lauderdale, FL Named on 20 payments
- Dale Mohar Kerrville, TX Named on 20 payments
- Vinay Sikand Toms River, NJ Named on 18 payments
- Sara Llerena Miami, FL Named on 17 payments
- Christine Vidouria San Antonio, TX Named on 16 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.